Related references
Note: Only part of the references are listed.Tristetraprolin Posttranscriptionally Downregulates TRAIL Death Receptors
Won Hyeok Lee et al.
CELLS (2020)
Genetics of rheumatoid arthritis: 2018 status
Yukinori Okada et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
RNA binding proteins in the control of autoimmune diseases
Masanori Yoshinaga et al.
IMMUNOLOGICAL MEDICINE (2019)
ZFP36 RNA-binding proteins restrain T cell activation and anti-viral immunity
Michael J. Moore et al.
ELIFE (2018)
Treatment of inflammatory arthritis via targeting of tristetraprolin, a master regulator of pro-inflammatory gene expression
E. A. Ross et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
The role of RNA-binding protein tristetraprolin in cancer and immunity
Jian Guo et al.
MEDICAL ONCOLOGY (2017)
Enhanced stability of tristetraprolin mRNA protects mice against immune-mediated inflammatory pathologies
Sonika Patial et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Tristetraprolin as a Therapeutic Target in Inflammatory Disease
Sonika Patial et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2016)
Dominant Suppression of Inflammation via Targeted Mutation of the mRNA Destabilizing Protein Tristetraprolin
Ewan A. Ross et al.
JOURNAL OF IMMUNOLOGY (2015)
Tristetraprolin regulation of interleukin-22 production
Lorena Haerdle et al.
SCIENTIFIC REPORTS (2015)
Genetics of rheumatoid arthritis contributes to biology and drug discovery
Yukinori Okada et al.
NATURE (2014)
Novel Risk Loci for Rheumatoid Arthritis in Han Chinese and Congruence With Risk Variants in Europeans
Lei Jiang et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Tristetraprolin (TTP): Interactions with mRNA and proteins, and current thoughts on mechanisms of action
Seth A. Brooks et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2013)
Suppression of IL-12 Production by Tristetraprolin through Blocking NF-κB Nuclear Translocation
Ling Gu et al.
JOURNAL OF IMMUNOLOGY (2013)
Tristetraprolin down-regulates IL-17 through mRNA destabilization
Hyun Hee Lee et al.
FEBS LETTERS (2012)
The role of tristetraprolin in cancer and inflammation
Sandhya Sanduja et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2012)
The roles of TTP and BRF proteins in regulated mRNA decay
Sandhya Sanduja et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2011)
Post-transcriptional control during chronic inflammation and cancer: a focus on AU-rich elements
Khalid S. A. Khabar
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
Tristetraprolin Impairs NF-κB/p65 Nuclear Translocation
Yvonne M. Schichl et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
RNA-destabilizing Factor Tristetraprolin Negatively Regulates NF-κB Signaling
Jian Liang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Tristetraprolin Mediates Interferon-γ mRNA Decay
Rachel L. Ogilvie et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Tristetraprolin (TTP) gene polymorphisms in patients with rheumatoid arthritis and healthy individuals
Takeshi Suzuki et al.
MODERN RHEUMATOLOGY (2008)
Phosphorylation site analysis of the anti-inflammatory and mRNA-destabilizing protein tristetraprolin
Heping Cao et al.
EXPERT REVIEW OF PROTEOMICS (2007)
Effects of infliximab therapy on gene expression levels of tumor necrosis factor α, tristetraprolin, T cell intracellular antigen 1, and Hu antigen R in patients with rheumatoid arthritis
Makoto Sugihara et al.
ARTHRITIS AND RHEUMATISM (2007)
Genetic variations in ZFP36 and their possible relationship to autoimmune diseases
Danielle Mercatante Carrick et al.
JOURNAL OF AUTOIMMUNITY (2006)
Arthritis suppressor genes TIA-1 and TTP dampen the expression of tumor necrosis factor α, cyclooxygenase 2, and inflammatory arthritis
K Phillips et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
An SNP map of human chromosome 22
JC Mullikin et al.
NATURE (2000)
Share Paper
